| Abbreviation | Definition |
| AIE | Aggregation-induced emission |
| ApoE3 | Apolipoprotein E3 |
| BBB | Blood–brain barrier |
| BBTB | Blood–brain tumour barrier |
| BET | Bromodomain and extra-terminal |
| BRD4 | Bromodomain-containing protein 4 |
| BSA | Bovine serum albumin |
| CCK-8 | Cell Counting Kit-8 |
| CDT | Chemodynamic therapy |
| CPP | Cell-penetrating peptide |
| DCFH-DA | 2′,7′-Dichlorodihydrofluorescein diacetate |
| DHE | Dihydroethidium |
| DHR123 | Dihydrorhodamine 123 |
| EPR | Electron paramagnetic resonance |
| ESR | Electron spin resonance |
| FITC | Fluorescein isothiocyanate |
| GBM | Glioblastoma |
| GICs | Glioma-initiating cells |
| GOx | Glucose oxidase |
| GPx1 | Glutathione peroxidase 1 |
| GSH | Glutathione |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| HSP70 | Heat shock protein 70 |
| HPF | Hydroxyphenyl fluorescein |
| ICP-MS | Inductively coupled plasma mass spectrometry |
| ISC | Intersystem crossing |
| LDLR | Low-density lipoprotein receptor |
| LRP1 | Low-density lipoprotein receptor-related protein 1 |
| MOF | Metal–organic framework |
| NO | Nitric oxide |
| OMVs | Outer membrane vesicles |
| OPN | Osteopontin |
| PBS | Phosphate-buffered saline |
| PDA | Polydopamine |
| PDT | Photodynamic therapy |
| PEG | Polyethylene glycol |
| PI | Propidium iodide |
| PROTAC | Proteolysis-targeting chimera |
| PTT | Photothermal therapy |
| ROS | Reactive oxygen species |
| SOSG | Singlet Oxygen Sensor Green |
| TPP | Triphenylphosphonium |
| TUNEL | Terminal deoxynucleotidyl transferase dUTP nick-end labeling |